Lung Cancer Digital Care Pathway

Monitor, analyse and act on the health outcomes that matter most to your lung cancer patients.

Higher Quality Care At Your Fingertips

As oncological therapies for lung cancer have improved, so has patient survivorship. But, studies show that survivorship does not equate to improved Quality of Life (QoL). [1]

To improve the outcomes and overall QoL of lung cancer patients, evidence-based care pathways are needed that consider the effects lung cancer and treatment have on their patients’ physical, social, and mental states.

The power of patient-reported outcomes (PROs) in lung cancer have been studied and results show that lung cancer patients who are PRO responders have significantly better health than non-responders. [2]

Only the patient can tell us how their lives have been affected by their condition and treatment. ZEDOC’s lung cancer digital care pathway is a validated solution for capturing their voice and bringing it into the care journey.

Lung cancer digital care pathway ZEDOC platform images

About the Pathway

This lung cancer care pathway is based on the International Consortium of Health Outcomes Measurement’s (ICHOM) Standard Set, which has been developed, tested, and validated by leading researchers and patient groups from around the world.

Patient Cohort & Treatment Type

  • Cohort:

    • Small Cell and Non-Small Cell Lung Cancer

  • Treatment Types:

    • Surgery

    • Radiotherapy

    • Chemotherapy

    • Targeted therapy

    • Immunotherapy

    • Others

Schedule

  • Baseline, pre-treatment

  • 3 months post-treatment initiation

  • 6 months post-treatment initiation

  • 1 year post-treatment initiation

  • 2 years post-treatment initiation

  • 3 years post-treatment initiation

  • Annually for 10 years post-treatment initiation

Patient-Reported Outcome Measures

  • EORTC-QLQ-C30 (Key QoL Function Domains)

    • Physical - Role - Cog. - Emotional - Social

  • EORTC QLQ-LC13 (Lung Cancer Symptoms)

Key Benefits

  • Measure

    Get comprehensive insight into your patients’ overall quality of life and lung cancer symptoms to measure the key outcomes of care delivery.

  • Improve

    Use the PROM data from each patient to enhance patient-clinician communication, inform treatment and detect oncological emergencies.

  • Automate

    Reduce the burden and time spent collecting patient-reported data by automating outreach, collection, and analysis of outcomes.

How it works

 
Digital Care Pathway journey icon
 

ZEDOC has patient-facing and provider-facing apps that enable patient-reported outcomes to be simply collected and reported back to care teams in real-time.

For Patients

At each point in the outcomes schedule, ZEDOC automatically communicates with patients (via SMS or Email) on behalf of the care team, sending secure links to their digital PROMs.

ZEDOC’s low friction patient app allows people to report their condition on their own devices, from anywhere. Key features include:

  • No download required

  • Accessibility settings to improve usability

  • Interactive elements that go beyond surveys

For Providers

With a centralised Provider Portal, ZEDOC turns raw PROM data into meaningful insights via interactive and real-time clinical dashboards.

Set up is simple and fast, with our team able to help you organise licenses for the instruments and get your staff trained with the system.
Key features include:

  • Set up within one week (pending licensing)

  • Billing managed either monthly or yearly

Interested in the pathway?

Complete the sign up form and our team will get in touch to personally walk you through the care pathway and answer any of your questions

"The association of QoL with survival PROs use appears to be a strong and independent factor in the prediction of survival in lung cancer”

Basch E, Deal A, Dueck A, Scher H, Kris M, Hudis C et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017;318(2):197.

Cavanna L, Citterio C, Orlandi E. Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer. Patient Related Outcome Measures. 2020;11:49–66.

Want to develop your own digital care pathway to reduce costs, improve outcomes and drive better value?

References

  1. Basch E, Deal A, Dueck A, Scher H, Kris M, Hudis C et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017;318(2):197.

  2. Brønserud M, Iachina M, Green A, Groenvold M, Dørflinger L, Jakobsen E. Patient-reported outcomes (PROs) in lung cancer: Experiences from a nationwide feasibility study. Lung Cancer. 2019;128:67-73.

  3. Cavanna L, Citterio C, Orlandi E. Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer. Patient Related Outcome Measures. 2020;11:49–66.